The Philippine drug regulator has already issued an emergency use authorization to the COVID-19 vaccine manufactured by Bharat Biotech in India. Just last week Bharat submitted a certificate for good manufacturing practices, completing the requirement for exporting Covaxin, FDA chief Eric Domingo said on Friday, June 25, 2021.
“Ngayon maaari na po silang mag-import. Maaari na pong gamitin din dito sa bansa po natin.” According to Bharat they are able to produce 23 million vaccines per month.
In the news of CNBC-TV18, it appeared that the efficacy or effectiveness of Covaxin reached 77.8% in its phase-3 data.
The cost of the vaccine for foreign governments is estimated at $ 15- $ 20 per dose.
16/5 – Covaxin gets international recognition by CID Oxford press
20/5 – BB added extra capacity of 200 million to existing one
30/5 – misinformation bout not approved (still in the process)
8/6 – Brazil approval
Share your thoughts and comment in the discussion box below!